Anika Therapeutics
ANIK
#9063
Rank
NZ$0.32 B
Marketcap
NZ$24.10
Share price
-2.50%
Change (1 day)
42.16%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): NZ-$0.44

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.47. In 2025 the company made an earnings per share (EPS) of NZ-$1.38 an increase over its 2024 EPS that were of NZ-$6.99.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.44-67.83%
2025NZ-$1.38-80.26%
2024NZ-$6.99-31.86%
2023NZ-$10.26448.54%
2022NZ-$1.87-455.17%
2021NZ$0.53-115.68%
2020NZ-$3.36-195.85%
2019NZ$3.5048.46%
2018NZ$2.36-40.37%
2017NZ$3.96-1.8%
2016NZ$4.037.77%
2015NZ$3.74-21.37%
2014NZ$4.7674.67%
2013NZ$2.7270.45%
2012NZ$1.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.12-2,669.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.41-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
NZ$17.15-3,734.62%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$6.39-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA